View Older Stories View More Recent Stories

May 11, 2022 04:22PM Salarius Pharmaceuticals, Inc. (SLRX) Completes SP-3164 Related Meeting with FDA, Plans to Submit IND in 2023
May 11, 2022 04:05PM Salarius Pharmaceuticals Completes SP-3164 Pre-Investigational New Drug Meeting Process with the U.S. Food and Drug Administration
May 5, 2022 07:30AM Salarius Pharmaceuticals to Report First Quarter 2022 Financial Results and Highlight Recent Company Progress
Apr 22, 2022 08:30AM Salarius Pharmaceuticals, Inc. (SLRX) Prices 9.34M Share Direct Offering at $0.25/sh
Apr 22, 2022 08:30AM Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
Mar 10, 2022 04:05PM Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2021 Financial Results
Mar 3, 2022 07:31AM Salarius Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results and Highlight Recent Company Progress
Feb 17, 2022 08:01AM Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational 2022 Virtual Conference
Feb 8, 2022 08:00AM Salarius Pharmaceuticals to Participate in the 2022 BIO CEO & Investor Conference
Feb 3, 2022 07:30AM Salarius Pharmaceuticals Appoints Daniela Santiesteban, Ph.D., to Director of Targeted Protein Degradation Program
Jan 13, 2022 07:03AM Salarius Pharmaceuticals, Inc. (SLRX) Acquires Targeted Protein Degradation Portfolio from DeuteRx
Jan 13, 2022 07:00AM Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC
Jan 6, 2022 12:45PM Salarius Pharmaceuticals to Present at Virtual H.C. Wainwright BioConnect, Participate in Virtual Biotech Showcase and BIO Partnering @ JPM During "J.P. Morgan Week 2022"
Dec 29, 2021 08:04AM Salarius Pharmaceuticals, Inc. (SLRX) Announced Achievement of Dosing Milestone in Ongoing Phase 1/2 Sarcoma Trial
Dec 29, 2021 08:03AM Salarius Pharmaceuticals Achieves Dosing Milestone in Ongoing Phase 1/2 Sarcoma Trial
Dec 15, 2021 08:31AM Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
Nov 29, 2021 08:01AM Salarius Pharmaceuticals to Participate in Annual Benchmark Company Discovery One-on-One Conference
Nov 4, 2021 04:05PM Salarius Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Oct 26, 2021 08:01AM Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company Progress
Oct 7, 2021 09:05AM Salarius Pharmaceuticals and Nationwide Children’s Hospital Disclose Research Findings from Presentation at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Thera
Oct 5, 2021 08:01AM Salarius Pharmaceuticals to Present at the 2021 BioFuture Conference
Sep 30, 2021 04:35PM Salarius Pharmaceuticals and Nationwide Children’s Hospital Announce Poster Presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Sep 28, 2021 07:01AM Salarius Pharmaceuticals Receives $2.7 Million in Payment from the Cancer Prevention and Research Institute of Texas
Sep 27, 2021 08:03AM Salarius Pharmaceuticals to Present at the Virtual Benzinga Healthcare Small Cap Conference
Sep 22, 2021 07:33AM Salarius Pharmaceuticals, Inc. (SLRX) Announces Research Partnership With Fox Chase Cancer Center
Sep 22, 2021 07:33AM Salarius Pharmaceuticals and Fox Chase Cancer Center Launch Research Partnership
Sep 20, 2021 07:33AM Salarius Pharmaceuticals Added to FTSE Global Micro Cap Index
Sep 15, 2021 08:03AM Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
Sep 8, 2021 08:13AM Salarius Pharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
Aug 12, 2021 02:00PM Salarius Pharmaceuticals to Present at the Virtual Diamond Equity Research Emerging Growth Invitational
Aug 5, 2021 07:32AM Salarius Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Jul 29, 2021 07:33AM Salarius Pharmaceuticals to Report Second Quarter 2021 Financial Results
Jul 14, 2021 08:05AM Salarius Pharmaceuticals Announces Aundrietta Duncan, Ph.D., To Present During Virtual Epigenetic Therapeutic Targets Summit
Jul 13, 2021 07:33AM Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas
Jul 9, 2021 07:33AM Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference
Jun 17, 2021 08:03AM REMINDER: Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event
Jun 15, 2021 07:42AM Salarius Pharmaceuticals (SLRX) Announces New Clinical Trial to Study Seclidemstat in Hematologic Cancers
Jun 15, 2021 07:30AM Salarius Pharmaceuticals Announces New Clinical Trial to Study Seclidemstat in Hematologic Cancers
Jun 10, 2021 01:30PM Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event
Jun 7, 2021 07:38AM Salarius Pharmaceuticals, Inc. (SLRX) Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology
Jun 7, 2021 07:35AM Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
May 19, 2021 05:01PM Salarius Pharmaceuticals Discloses Key Findings from Three Abstracts to be Presented at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
May 12, 2021 04:05PM Salarius Pharmaceuticals Reports First Quarter Financial Results with Business Highlights
May 5, 2021 07:05AM Salarius Pharmaceuticals to Report First Quarter 2021 Financial Results
Apr 29, 2021 07:30AM Salarius Pharmaceuticals Announces Titles of Three Abstracts Accepted for Poster Presentations at American Society of Clinical Oncology 2021 Annual Meeting
Apr 19, 2021 07:30AM Salarius Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentations at the 2021 American Society of Clinical Oncology Annual Meeting
Mar 18, 2021 04:05PM Salarius Pharmaceuticals Reports Business Highlights with Fourth Quarter and Full-Year 2020 Financial Results
Mar 11, 2021 04:15PM Salarius Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results
Feb 22, 2021 07:30AM Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Virtual Conference
Dec 11, 2020 11:32AM Salarius Announces Exercise Of Warrants For $3.5 Million Of Gross Proceeds To Be Used For Ongoing Development Of Seclidemstat
View More Recent Stories View Older Stories